JP6748188B2 - 化合物ｎ−（３，５−ジメチルフェニル）−ｎ’−（２−トリフルオロメチルフェニル）グアニジンの調製方法 - Google Patents

化合物ｎ−（３，５−ジメチルフェニル）−ｎ’−（２−トリフルオロメチルフェニル）グアニジンの調製方法 Download PDF

Info

Publication number
JP6748188B2
JP6748188B2 JP2018506997A JP2018506997A JP6748188B2 JP 6748188 B2 JP6748188 B2 JP 6748188B2 JP 2018506997 A JP2018506997 A JP 2018506997A JP 2018506997 A JP2018506997 A JP 2018506997A JP 6748188 B2 JP6748188 B2 JP 6748188B2
Authority
JP
Japan
Prior art keywords
formula
compound
solid form
crystalline solid
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2018506997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018525393A5 (https=
JP2018525393A (ja
Inventor
アマト，ホセ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Research SL
Original Assignee
Chemo Research SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Research SL filed Critical Chemo Research SL
Publication of JP2018525393A publication Critical patent/JP2018525393A/ja
Publication of JP2018525393A5 publication Critical patent/JP2018525393A5/ja
Application granted granted Critical
Publication of JP6748188B2 publication Critical patent/JP6748188B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/02—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of guanidine from cyanamide, calcium cyanamide or dicyandiamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/06—Purification or separation of guanidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2018506997A 2015-08-11 2016-08-10 化合物ｎ−（３，５−ジメチルフェニル）−ｎ’−（２−トリフルオロメチルフェニル）グアニジンの調製方法 Expired - Fee Related JP6748188B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15382424.8 2015-08-11
ARP150102582A AR101498A1 (es) 2015-08-11 2015-08-11 Procedimiento para la preparación del compuesto n-(3,5-dimetilfenil)-n-(2-trifluorometilfenil)guanidina y su forma cristalina a
EP15382424 2015-08-11
ARP20150102582 2015-08-11
PCT/EP2016/069033 WO2017025560A1 (en) 2015-08-11 2016-08-10 A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine

Publications (3)

Publication Number Publication Date
JP2018525393A JP2018525393A (ja) 2018-09-06
JP2018525393A5 JP2018525393A5 (https=) 2019-08-15
JP6748188B2 true JP6748188B2 (ja) 2020-08-26

Family

ID=56799434

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018506997A Expired - Fee Related JP6748188B2 (ja) 2015-08-11 2016-08-10 化合物ｎ−（３，５−ジメチルフェニル）−ｎ’−（２−トリフルオロメチルフェニル）グアニジンの調製方法

Country Status (21)

Country Link
US (1) US10343984B2 (https=)
EP (1) EP3334707B1 (https=)
JP (1) JP6748188B2 (https=)
CN (1) CN107922322B (https=)
AR (1) AR101498A1 (https=)
BR (1) BR112018002614B1 (https=)
CA (1) CA2994781A1 (https=)
CY (1) CY1122481T1 (https=)
DK (1) DK3334707T3 (https=)
ES (1) ES2756580T3 (https=)
HR (1) HRP20192301T1 (https=)
HU (1) HUE046959T2 (https=)
LT (1) LT3334707T (https=)
MX (1) MX383481B (https=)
PL (1) PL3334707T3 (https=)
PT (1) PT3334707T (https=)
RS (1) RS59759B1 (https=)
RU (1) RU2737430C2 (https=)
SI (1) SI3334707T1 (https=)
SM (1) SMT201900747T1 (https=)
WO (1) WO2017025560A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172842B (https=) * 1990-05-17 1993-12-11 Boots Pharmaceuticals Limited
EP0910358A1 (en) * 1996-05-24 1999-04-28 Neurosearch A/S Phenyl derivatives useful as blockers of chloride channels
WO2010051129A2 (en) * 2008-10-03 2010-05-06 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Materiel Command New imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use
CN103917520B (zh) 2011-10-11 2016-08-24 基尔梅斯国立大学 苯基胍衍生物

Also Published As

Publication number Publication date
EP3334707B1 (en) 2019-10-09
RU2018107840A3 (https=) 2019-12-18
CN107922322B (zh) 2023-11-03
US10343984B2 (en) 2019-07-09
CN107922322A (zh) 2018-04-17
HUE046959T2 (hu) 2020-04-28
RU2018107840A (ru) 2019-09-12
BR112018002614B1 (pt) 2023-04-11
HRP20192301T1 (hr) 2020-03-20
LT3334707T (lt) 2020-01-27
DK3334707T3 (da) 2020-01-06
PL3334707T3 (pl) 2020-05-18
PT3334707T (pt) 2020-01-14
SMT201900747T1 (it) 2020-03-13
US20180244608A1 (en) 2018-08-30
HK1256253A1 (en) 2019-09-20
MX383481B (es) 2025-03-14
SI3334707T1 (sl) 2020-03-31
ES2756580T3 (es) 2020-04-27
RS59759B1 (sr) 2020-02-28
AR101498A1 (es) 2016-12-21
JP2018525393A (ja) 2018-09-06
CA2994781A1 (en) 2017-02-16
CY1122481T1 (el) 2021-01-27
MX2018001548A (es) 2018-06-22
BR112018002614A2 (https=) 2018-10-02
WO2017025560A1 (en) 2017-02-16
EP3334707A1 (en) 2018-06-20
RU2737430C2 (ru) 2020-11-30

Similar Documents

Publication Publication Date Title
EA037521B1 (ru) Противогрибковые соединения и способы их получения
TWI772424B (zh) 一種苯并呋喃類衍生物游離鹼的晶型及製備方法
WO2012051246A1 (en) Tapentadol hydrobromide and crystalline forms thereof
JP2015522037A (ja) ベムラフェニブコリン塩の固体形態
JP2023157909A (ja) ２－（５－（４－（２－モルホリノエトキシ）フェニル）ピリジン－２－イル）－ｎ－ベンジルアセトアミドの固体形態
CN117203208A (zh) 靶向活化与失活态kras g12d的抑制剂
KR20090122218A (ko) ５-(２,４-디히드록시-５-이소프로필-페닐)-４-(４-모르폴린-４-일메틸-페닐)-이속사졸-３-카르복실산 에틸아미드의 산 부가염, 수화물 및 다형체, 및 이들 형태를 포함하는 제제
KR20200123184A (ko) 증식이상 장애를 치료하기 위한 물질 및 방법
JP6748188B2 (ja) 化合物ｎ−（３，５−ジメチルフェニル）−ｎ’−（２−トリフルオロメチルフェニル）グアニジンの調製方法
JP2018521055A (ja) サクビトリルカルシウム塩
US11466008B2 (en) Co-crystals of neflamapimod (VX-745)
EP3526217B1 (en) Crystalline forms of 4-(2-((1r,2r)-2-hydroxycyclohexylamino) benzothiazol-6-yloxy)-n-methylpicolinamide
JP6317358B2 (ja) Ｌ‐リジンを含む（３ｓ，３ｓ’）４，４’‐ジスルファンジイルビス（３‐アミノブタン１‐スルホン酸）の新規結晶相
HK1256253B (en) A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine
WO2014182673A1 (en) Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
JP7064527B2 (ja) サクビトリルカルシウム塩
WO2019109802A1 (zh) 一种取代的硼酸酯化合物的制备方法及其晶型
RU2802964C2 (ru) Твердые формы 2-(5-(4-(2-морфолиноэтокси)фенил)пиридин-2-ил)-n-бензилацетамида
AU2024363740A1 (en) Pharmaceutically acceptable salt of a cd47-sirp alpha pathway inhibitor
JP2024532601A (ja) インドール化合物の固体形態、その調製方法及びその使用
WO2014182688A1 (en) Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
KR20210155806A (ko) Pi3k 저해제의 결정다형 및 이의 제조방법
HK40069001B (zh) 活化素受体样激酶抑制剂的盐和晶体形式
TW201329024A (zh) （２ｓ）－２－胺基－３－羥基－ｎ－［２－甲氧基－２－［（１ｚ）－２－（３，４，５－三甲氧基苯基）乙烯基］苯基］丙醯胺之新穎晶型及其製備方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190703

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190703

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200325

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200624

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200714

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200806

R150 Certificate of patent or registration of utility model

Ref document number: 6748188

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees